Comparison of Laryngeal Mask Airway (LMA®) and Tracheal Tube in Modified Radical Mastectomy on Breast Cancer

Comparison of Laryngeal Mask Airway (LMA®) and Tracheal Tube for Airway Management in Modified Radical Mastectomy on Breast Cancer

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00638599

Acronym

LMATBBC

Enrollment

200

Registered

2008-03-19

Start date

2008-01-31

Completion date

2009-07-31

Last updated

2009-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Intubation, intratracheal, Homeostasis, Mastectomy, modified radical, Breast Neoplasms

Brief summary

Airway management in anesthesia is critical to guarantee appropriate treatment of possible respiratory complications and successful operative practice. LMA® is an alternative to tracheal tube in some surgeries like as mastectomy on breast cancer. Given no need using muscular relaxants in mastectomy, the investigators hypothesized that LMA® would be a superior manner in airway management in radical modified mastectomy on breast cancer than the tracheal tube, and the LMA® might produce less influence on patients' circulatory homeostasis, and easier to be placed before operation.

Interventions

DEVICELMA®

LMA® is placed after anesthesia induction and removed after the operation

DEVICEEndotracheal tube

Standard endotracheal tube is inserted after anesthesia induction and extubated after the operation

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Chinese * Diagnosed breast cancer * Undergoing modified radical mastectomy * Agreed to participate the study with informed contract.

Exclusion criteria

* Organic dysfunction * Long-lasting post-anesthetic care unit(PACU) staying.

Design outcomes

Primary

Measure	Time frame
Circulatory Homeostasis	15min prior to operation to 15min posterior to operation

Secondary

Measure	Time frame
Airway pressure	15min prior to operation to 15min posterior to operation
Blood gas	15min prior to operation to 15min posterior to operation
Airway complications	Start of operation to 6h after operation

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026